Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Teladoc (TDOC) Receives a Buy from Canaccord Genuity
11:08am, Friday, 06'th Mar 2020
Canaccord Genuity analyst Richard Close reiterated a Buy rating on Teladoc (TDOC) yesterday and set a price target of $130.00. The company's shares closed
Teladoc (TDOC) Receives a Buy from Canaccord Genuity
11:08am, Friday, 06'th Mar 2020
Canaccord Genuity analyst Richard Close reiterated a Buy rating on Teladoc (TDOC – Research Report) yesterday and set a price
Canaccord Genuity Keeps Their Buy Rating on Health Insurance Innovations (HIIQ)
11:06am, Wednesday, 04'th Mar 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Health Insurance Innovations (HIIQ), with a price target
Canaccord Genuity Keeps Their Buy Rating on Health Insurance Innovations (HIIQ)
11:06am, Wednesday, 04'th Mar 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Health Insurance Innovations (HIIQ –
Allscripts (MDRX) Gets a Hold Rating from Cantor Fitzgerald
02:42pm, Tuesday, 03'rd Mar 2020
Cantor Fitzgerald analyst Steven Halper reiterated a Hold rating on Allscripts (MDRX) today and set a price target of $8.00. The company's shares closed
Canaccord Genuity Sticks to Their Buy Rating for Allscripts (MDRX)
11:09am, Tuesday, 03'rd Mar 2020
Canaccord Genuity analyst Richard Close reiterated a Buy rating on Allscripts (MDRX) yesterday and set a price target of $13.00. The company's shares
Canaccord Genuity Sticks to Their Buy Rating for Allscripts (MDRX)
11:09am, Tuesday, 03'rd Mar 2020
Canaccord Genuity analyst
Richard Close
reiterated a
Buy
rating on Allscripts (
MDRX
–
Research Report
) yesterday and set a price target of
$13.00
. The company’s shares closed last Monday at $7.
Canaccord Genuity Reaffirms Their Buy Rating on Livongo Health (LVGO)
11:09am, Tuesday, 03'rd Mar 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Livongo Health (LVGO), with a price target of $46.00. The
Canaccord Genuity Reaffirms Their Buy Rating on Livongo Health (LVGO)
11:09am, Tuesday, 03'rd Mar 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Livongo Health (LVGO – Research
Cantor Fitzgerald Comments on Evolent Health Inc's FY2020 Earnings (NYSE:EVH)
08:46am, Tuesday, 03'rd Mar 2020
Evolent Health Inc (NYSE:EVH) – Analysts at Cantor Fitzgerald dropped their FY2020 earnings per share estimates for shares of Evolent Health in a research note issued to investors on Wednesday, Febr
Analysts Offer Predictions for Evolent Health Inc's Q1 2020 Earnings (NYSE:EVH)
08:20am, Tuesday, 03'rd Mar 2020
Evolent Health Inc (NYSE:EVH) – Investment analysts at Piper Sandler lowered their Q1 2020 earnings per share estimates for shares of Evolent Health in a note issued to investors on Wednesday, Febru
Evolent Health Recaps 2019 Year in Review
09:05pm, Monday, 02'nd Mar 2020
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced several significant achievements i
This local bio wants to swiftly deliver a coronavirus vaccine. It will need some help.
08:12pm, Monday, 02'nd Mar 2020
Gaithersburg’s Altimmune is working on a vaccine for the COVID-19 coronavirus.
These local companies have taken the biggest hits on Wall Street during current sell-off
01:45pm, Monday, 02'nd Mar 2020Evolent Health, Inc. Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
07:01pm, Thursday, 27'th Feb 2020
It's been a mediocre week for Evolent Health, Inc. (NYSE:EVH) shareholders, with the stock dropping 16% to US$9.75 in...
